SynthesisClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Risk Factors Associated With Venous Thromboembolism in Individuals With COPD: A Systematic Review and Meta-analysis.
Synthesis in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Pathogenesis and Phenotypes of Pulmonary Vascular Disease in COPD: A Consensus Statement From the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative - PH Group 3 Workstream.Pulmonary circulation · 2026Article
- Superficial femoral artery thrombosis after PFNA in an intertrochanteric fracture patient with sarcopenia and copd: a rare case report.BMC geriatrics · 2026Article
- Interpretable machine learning models to predict venous thromboembolism in sepsis patients with type 2 diabetes mellitus.Frontiers in endocrinology · 2026Article
- Observational
- Explainable Machine Learning for Predicting Deep Vein Thrombosis in Critically Ill Patients with COPD: Development and Multicenter External Validation.International journal of chronic obstructive pulmonary disease · 2026Article
- Incidence and risk factors of venous and arterial thromboembolism events in lung cancer patients treated with immune checkpoint inhibitors.Frontiers in pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveCurrently, no comprehensive analysis of the risk factors for venous thromboembolism (VTE) in chronic obstructive pulmonary disease (COPD) patients has been reported. We aimed to explore the risk factors for VTE among individuals with COPD using meta-analysis.MethodsPubMed, Cochrane Library, Web of Science and Embase were searched from database to February 2025 for case-control and cohort studies that assessed the risk factors for VTE among COPD patients. Pooled odds ratios (ORs), mean differences (MDs) and 95% confidence intervals (CIs) were calculated to determine the risk factors.ResultsA total of 23 clinical studies were included. Being female, atelectasis, prolonged immobility, invasive mechanical ventilation, neoplasia and chest pain (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.